Progenitor cells in infantile hemangioma

Journal of Craniofacial Surgery

Volumn 20, Issue SUPPL. 1, 2009, Pages 695-697

  Bischoff, Joyce ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Endothelial progenitor cells; Hemangioma; Stem cells

Indexed keywords

ANGIOGENESIS; ARTICLE; CAPILLARY; CELL DIFFERENTIATION; CELL ISOLATION; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CONGENITAL BLOOD VESSEL MALFORMATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ERYTHROCYTE; HEMANGIOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; INFANT; INFANT DISEASE; INFANTILE HEMANGIOMA; INVOLUTION; LIFE CYCLE; MESODERM; MULTIPOTENT STEM CELL; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; STEM CELL; TUMOR GROWTH; CANCER STEM CELL; CELL LINEAGE; CHILD; HEAD AND NECK TUMOR; MESENCHYMAL STEM CELL; NEOVASCULARIZATION (PATHOLOGY); NEWBORN; PATHOLOGY; PRESCHOOL CHILD; REVIEW; TUMOR REGRESSION;

CELL LINEAGE; CHILD; CHILD, PRESCHOOL; HEAD AND NECK NEOPLASMS; HEMANGIOMA; HUMANS; INFANT; INFANT, NEWBORN; MESENCHYMAL STEM CELLS; MULTIPOTENT STEM CELLS; NEOPLASM REGRESSION, SPONTANEOUS; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 67650770131     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/SCS.0b013e318193d6ac     Document Type: Article

References (28)

1. Mulliken JB, Fishman SJ, Burrows PE. Vascular anomalies. Curr Probl Surg 2000;37:517-584
2. Haggstrom AN, Drolet BA, Baselga E, et al. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 2006;118:882-887
3. Metry DW, Haggstrom AN, Drolet BA, et al. A prospective study of PHACE syndrome in infantile hemangiomas: demographic features, clinical findings, and complications. Am J Med Genet A 2006;140:975-986
4. Barlow CF, Priebe CJ, Mulliken JB, et al. Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy. J Pediatr 1998;132;527-530
5. Ezekowitz RA, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 1992;326:1456-1463
6. Chang E, Boyd A, Nelson CC, et al. Successful treatment of infantile hemangiomas with interferon-alpha-2b. J Pediatr Hematol Oncol 1997;19:237-244
7. Greinwald JH Jr, Burke DK, Bonthius DJ, et al. An update on the treatment of hemangiomas in children with interferon alfa-2a. Arch Otolaryngol Head Neck Surg 1999;125:21-27
8. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649-2651
9. Takahashi K, Mulliken JB, Kozakewich HP, et al. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 1994;93:2357-2364
10. Smoller BR, Apfelberg DB. Infantile (juvenile) capillary hemangioma: a tumor of heterogeneous cellular elements. J Cutan Pathol 1993;20:330-336
11. Mancini AJ, Smoller BR. Proliferation and apoptosis within juvenile capillary hemangiomas. Am J Dermatopathol 1996;18:505-514
12. Verkarre V, Patey-Mariaud de Serre N, Vazeux R, et al. ICAM-3 and E-selectin endothelial cell expression differentiate two phases of angiogenesis in infantile hemangiomas. J Cutan Pathol 1999;26:17-24
13. Patey N, Vazeux R, Canioni D, et al. Intercellular adhesion molecule-3 on endothelial cells. Expression in tumors but not in inflammatory responses. Am J Pathol 1996;148:465-472
14. Mulliken JB, Zetter BR, Folkman J. In vitro characteristics of endothelium from hemangiomas and vascular malformations. Surgery 1982;92:348-353
15. Dosanjh A, Chang J, Bresnick S, et al. In vitro characteristics of neonatal hemangioma endothelial cells: similarities and differences between normal neonatal and fetal endothelial cells. J Cutan Pathol 2000;27:441-450
16. Boye E, Yu Y, Paranya G, et al. Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest 2001;107:745-752
17. Walter JW, North PE, Waner M, et al. Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma. Genes Chromosomes Cancer 2002;33:295-303
18. Yu Y, Flint AF, Mulliken JB, et al. Endothelial progenitor cells in infantile hemangioma. Blood 2004;103:1373-1375
19. Khan ZA, Melero-Martin JM, Wu X, et al. Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin. Blood 2006;108:915-921
20. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997;88:277-285
21. + endothelial progenitor cells in children with hemangioma. Lymphat Res Biol 2003;1:301-307
22. Bauland CG, van Steensel MA, Steijlen PM, et al. The pathogenesis of hemangiomas: a review. Plast Reconstr Surg 2006;117:29e-35e
23. Pack GT, Miller TR. Hemangiomas; classification, diagnosis and treatment. Angiology 1950;1:405-426
24. Nguyen VA, Fürhapter C, Romani N, et al. Infantile hemangioma is a proliferation of beta 4-negative endothelial cells adjacent to HLA-DR-positive cells with dendritic cell morphology. Hum Pathol 2004;35:739-744
25. Dadras SS, North PE, Bertoncini J, et al. Infantile hemangiomas are arrested in an early developmental vascular differentiation state. Mod Pathol 2004;17:1068-1079
26. Xu H, Edwards JR, Espinosa O, et al. Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors. Hum Pathol 2004;35:857-861
27. Khan ZA, Boscolo E, Picard A, et al. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest 2008
28. Yu Y, Fuhr J, Boye E, et al. Mesenchymal stem cells and adipogenesis in hemangioma involution. Stem Cells 2006;24:1605-1612